Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MediciNova to acquire Avigen for $1.24 a share
Marketwatch
Friday, August 21, 2009 - 7:37am
tags:
MediciNova, Avigen, M&A
Data could personalize use of Iressa, Tarceva
Fierce Pharma
Thursday, August 20, 2009 - 5:08pm
tags:
Tarceva, Iressa, personalized medicine, lung cancer, Roche, AstraZeneca
Bristol-Myers extends Medarex tender deadline
Marketwatch
Thursday, August 20, 2009 - 5:06pm
tags:
Bristol-Myers Squibb, Medarex, M&A
Cornerstone Falls Short
Yahoo/Zacks.com
Thursday, August 20, 2009 - 5:05pm
tags:
Cornerstone Therapeutics, AstraZeneca, earnings, Merck
Lilly to Pay $15.75 Million to West Virginia in Zyprexa Suit
Bloomberg
Thursday, August 20, 2009 - 4:08pm
tags:
West Virginia, Eli Lilly, lawsuits, settlements, Zyprexa
AVI BioPharma announces stock offering pricing; shares tumble
Bizjournals.com
Thursday, August 20, 2009 - 4:05pm
tags:
AVI BioPharma, stock offering
Zymogenetics says rival’s product could be deadly
Bizjournals.com
Thursday, August 20, 2009 - 4:03pm
tags:
ZymoGenetics, Thrombin, King
Results in The New England Journal of Medicine confirm Novartis drug Femara is superior to tamoxifen after breast cancer surgery
Fierce Biotech
Thursday, August 20, 2009 - 10:58am
tags:
Novartis, New England Journal of Medicine, breast cancer, Femara, tamoxifen
Biotech stocks gain; Anika rockets on drug approval
Marketwatch
Thursday, August 20, 2009 - 10:56am
tags:
biotech, Anika, Monovisc
FDA approves GlaxoSmithKline's Hiberix vaccine
Yahoo/AP
Thursday, August 20, 2009 - 10:40am
tags:
GSK, FDA, Hiberix, meningitis
BioDelivery Sciences: Attractive Under $5
Seeking Alpha
Thursday, August 20, 2009 - 8:48am
tags:
BioDelivery Sciences
Hospira Restarts Shipments Of Generic Cancer Drug
WSJ Online
Thursday, August 20, 2009 - 8:39am
tags:
Hospira, Eloxatin, cancer, Sanofi
Summary Box: Glaxo used ghostwriting to push Paxil
Yahoo/AP
Thursday, August 20, 2009 - 8:34am
tags:
GSK, Ghostwriting
The Medicines Co: No Non-Sinister Deed Goes Unpunished
InVivo
Thursday, August 20, 2009 - 8:29am
tags:
Medicines Company
Teva Pharmaceutical: Predictable Growth, Good Value
Seeking Alpha
Thursday, August 20, 2009 - 7:17am
tags:
Teva Pharmaceuticals, Forest Labs, Mylan, Watson Pharmaceuticals, Impax Labs
Why Pharma Wants ObamaCare: There are reasons it could be good for drug companies--and they're not what you think
Forbes
Thursday, August 20, 2009 - 7:16am
tags:
healthcare reform
Pfizer will make clinical trial networking site
Pfizer
Thursday, August 20, 2009 - 6:19am
tags:
drug trials, clinical trials, Pfizer
Tough Decisions on Osteoporosis Drugs
Businessweek
Thursday, August 20, 2009 - 6:18am
tags:
osteoporosis, Amgen, Eli Lilly, denosumab, arzoxifene, FDA
Vaccine Surprise Redeems AstraZeneca’s MedImmmune Buy
Bloomberg
Thursday, August 20, 2009 - 6:17am
tags:
vaccines, AstraZeneca, MedImmune, M&A, swine flu, H1N1
Disclosure trend hits PBM-drugmaker deals
Fierce Pharma
Wednesday, August 19, 2009 - 6:39pm
tags:
PBMs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.